0001213900-23-041748.txt : 20230522 0001213900-23-041748.hdr.sgml : 20230522 20230522085525 ACCESSION NUMBER: 0001213900-23-041748 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20230522 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20230522 DATE AS OF CHANGE: 20230522 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Gamida Cell Ltd. CENTRAL INDEX KEY: 0001600847 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38716 FILM NUMBER: 23942551 BUSINESS ADDRESS: STREET 1: 5 NAHUM HAFZADI STREET CITY: JERUSALEM STATE: L3 ZIP: 95484 BUSINESS PHONE: 97226595666 MAIL ADDRESS: STREET 1: 5 NAHUM HAFZADI STREET CITY: JERUSALEM STATE: L3 ZIP: 95484 8-K 1 ea179036-8k_gamida.htm CURRENT REPORT

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 22, 2023

Gamida Cell Ltd.

(Exact name of registrant as specified in its Charter)

Israel		001-38716		Not Applicable
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

116 Huntington Avenue, 7th Floor, Boston, MA		02116
(Address of principal executive offices)		(Zip Code)

(617) 892-9080

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Ordinary Shares, NIS 0.01 par value		GMDA		The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On May 22, 2023, Gamida Cell Ltd. (the “Company”) announced the appointment of Terry Coelho as the Company’s Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer, effective May 22, 2023. Ms. Coelho serves as a paid consultant to the Company pursuant to an amended and restated consulting agreement, dated May 22, 2023, which provides for her compensation at an hourly rate of $500 for the first 25 hours of service per week and $400 for each additional hour per week thereafter. The Company has also agreed to recommend to the Company’s Board of Directors that Ms. Coelho be awarded options to purchase 10,000 ordinary shares of the Company pursuant to the Company’s 2017 Share Incentive Plan, which options would vest on the earlier of a merger or sale transaction, on the one hand, or May 22, 2024, on the other. Ms. Coelho’s consulting arrangement runs through December 31, 2023.

Ms. Coelho, age 62, has more than 35 years of experience as a multinational leader and executive with broad business, strategic and leadership experience in general management and across all areas of finance at public and private companies in multiple sectors, including pharmaceuticals. She most recently served as Executive Vice President, Chief Financial Officer and Chief Business Development Officer for CinCor Pharma, Inc, from November 2021 through November 2022. Prior to that, Ms. Coelho served in executive leadership roles, including Executive Vice President and Chief Financial Officer at BioDelivery Sciences International from January 2019 to October 2021, and Chief Financial Officer at Balchem Corporation from October 2017 to October 2018, and as Division Chief Financial Officer and Division Chief Operating Officer at Diversey, Inc. from October 2014 to August 2017, after which Diversey was acquired by Bain Capital and Ms. Coelho served as Chief Financial Officer and Chief Operating Officer from September 2017 to October 2017. Ms. Coelho’s experience includes more than seven years at Novartis Pharmaceuticals, primarily with the Oncology division, where she held leadership roles of increasing responsibility focused in business planning in commercial oncology, and at Sandoz leading global oncology development finance. She began her career at Mars, Inc. Ms. Coelho is a Member of the Board of Directors at HOOKIPA Pharma Inc. and First Wave BioPharma. She graduated summa cum laude from The American University School of International Service in Washington, D.C. and earned her masters of business administration from the Instituto Brasileiro de Mercado de Capitais (IBMEC) in Rio de Janeiro, Brazil. Ms. Coelho is a founding advisory board member of the CFO Leadership Council (Charlotte and Raleigh chapters) and has previously served on the advisory board for Northeastern University’s M.B.A. Finance Track and the University of North Carolina at Charlotte Women in Business.

On May 22, 2023, the Company also announced Shai Lankry would transition his role within the Company from Chief Financial Officer to Vice President, Finance beginning May 22, 2023 and will serve in such capacity until June 2, 2023, his final date of employment with the Company.

A copy of the press release issued by Company on May 22, 2023 is filed as Exhibit 99.1 hereto and incorporated by reference herein.

On May 19, 2023, the Company entered into agreements with certain of its executive officers under which such executive officers are eligible to receive retention and/or transaction bonuses. The Company’s Chief Executive Officer, Abbey Jenkins, is eligible to receive a special transaction bonus in the amount of $287,500 in consideration for her efforts to further a strategic transaction for the Company, provided that she is employed by the Company upon the consummation of such transaction (“Specified Criteria”). The Company’s Chief Operating and Chief Commercial Officer, Michele Korfin, Chief Medical and Chief Scientific Officer, Ronit Simantov, and General Counsel and Chief Compliance Officer, Josh Patterson, are each also eligible to receive transaction bonuses contingent upon the Specified Criteria in the amounts of $192,280, $192,280 and $180,000, respectively. Ms. Korfin, Dr. Simantov and Mr. Patterson also received retention bonuses in the same amounts, provided that such individual remains employed by the Company through January 30, 2024, or such earlier date that his or her employment is terminated without cause.

Item 9.01. Financial Statements and Exhibits.

Exhibit No.
99.1		Press Release, dated May 22, 2023
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

1

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	GAMIDA CELL LTD.

May 22, 2023	By:	/s/ Josh Patterson
		Josh Patterson
		General Counsel

2

EX-99.1 2 ea179036ex99-1_gamida.htm PRESS RELEASE, DATED MAY 22, 2023

Exhibit 99.1

Gamida Cell Appoints Terry Coelho as CFO

Industry veteran Coelho brings more than 35 years of experience at emerging growth
and global companies to role; Shai Lankry to depart June 2

BOSTON – May 22, 2023 - Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, today announced the appointment of Terry Coelho as chief financial officer effective immediately. Shai Lankry, who has served as the company’s CFO for the past five years, is stepping down as CFO today and will leave the company June 2.

The transition is part of a planned leadership change first shared with the investor community in August 2022 and designed to coincide with Gamida Cell’s evolution from a clinical to a commercial-stage company. Ms. Coelho is a seasoned finance executive with more than 35 years of experience across all areas of finance at emerging growth companies and established global companies.

“I want to thank Shai for his many contributions supporting the expansion and evolution of the company to include a more robust pipeline and operations in both the United States and Israel,” said Abbey Jenkins, President and Chief Executive Officer. “Terry has tremendous experience as CFO of commercial-stage biopharmaceutical companies. She will be a great partner to help us execute our two-pronged strategy of launching Omisirge and, in parallel, pursuing strategic partnerships to fully resource commercialization.”

Ms. Coelho currently serves as an independent director on the public company boards of First Wave BioPharma (Nasdaq: FWBI) and HOOKIPA Pharma (Nasdaq: HOOK) and she is chairperson of the audit committee and a member of the compensation committees for both companies. She most recently served as Executive Vice President, CFO and Chief Business Development Officer at CinCor Pharma, Inc., where she led the company’s successful initial public offering and follow-on financing in 2022. AstraZeneca acquired CinCor in February.

Ms. Coelho’s experience also includes serving as Executive Vice President and CFO at BioDelivery Sciences International, Inc., which was acquired by Collegium Pharmaceuticals in 2022, and as CFO at Balchem Corporation and Diversey, Inc. She held a series of senior financial and executive roles at Sealed Air Corporation, Mars, Inc. and Novartis Pharmaceuticals, where for seven years she held roles of increasing responsibility including as finance lead for the oncology hematology franchise and later leading global oncology development finance.

“Omisirge has great commercial potential and the opportunity to fill a critical need for patients in need of stem cell transplant,” said Ms. Coelho. “I’m excited to work with the team to help support Omisirge’s launch and find a partner that can help it fulfill its promise.”

Ms. Coelho earned an MBA in Finance from IBMEC in Brazil and Bachelor of Arts degrees in Economics and International Relations, summa cum laude, from The American University School of International Service in Washington, DC.

Omisirge^® (omidubicel-onlv) was recently approved by the U.S. Food and Drug Administration for patients with hematologic malignancies who are planned for allogeneic hematopoietic stem cell transplantation. Please see full Prescribing Information, including the Boxed Warning.

About Gamida Cell

Gamida Cell is a cell therapy pioneer working to turn cells into powerful therapeutics. The company’s proprietary nicotinamide (NAM) technology leverages the properties of NAM to enhance and expand cells, creating allogeneic cell therapy products and candidates that are potentially curative for patients with hematologic malignancies. These include Omisirge^®, an FDA-approved nicotinamide modified allogeneic hematopoietic progenitor cell therapy, and GDA-201, an intrinsic NK cell therapy candidate being investigated for the treatment of hematologic malignancies. For additional information, please visit www.gamida-cell.com or follow Gamida Cell on LinkedIn, Twitter, Facebook or Instagram.

Omisirge^® is a registered trademark of Gamida Cell Inc. © 2023 Gamida Cell Inc. All Rights Reserved.

Cautionary Note Regarding Forward Looking Statements

This press release contains forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995, including with respect to the potentially life-saving or curative therapeutic and commercial potential of Omisirge^® (omidubicel-onlv), the company’s plans for commercial or strategic partnerships to support the launch of Omisirge. Any statement describing Gamida Cell’s goals, expectations, financial or other projections, intentions or beliefs is a forward-looking statement and should be considered an at-risk statement. Such statements are subject to a number of risks, uncertainties and assumptions including those related to clinical, scientific, regulatory and technical developments and those inherent in the process of developing and commercializing product candidates that are safe and effective for use as human therapeutics. In light of these risks and uncertainties, and other risks and uncertainties that are described in the Risk Factors section and other sections of Gamida Cell’s Quarterly Report on Form 10-Q, filed with the Securities and Exchange Commission (SEC) on May 15, 2023, and other filings that Gamida Cell makes with the SEC from time to time (which are available at http://www.sec.gov), the events and circumstances discussed in such forward-looking statements may not occur, and Gamida Cell’s actual results could differ materially and adversely from those anticipated or implied thereby. Although Gamida Cell’s forward-looking statements reflect the good faith judgment of its management, these statements are based only on facts and factors currently known by Gamida Cell. As a result, you are cautioned not to rely on these forward-looking statements.

Investor and Media Contact:

Dan Boyle
Orangefiery

media@orangefiery.com
1-818-209-1692

GRAPHIC 3 ex99-1_001.jpg GRAPHIC begin 644 ex99-1_001.jpg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end EX-101.SCH 4 gmda-20230522.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 5 gmda-20230522_lab.xml XBRL LABEL FILE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 6 gmda-20230522_pre.xml XBRL PRESENTATION FILE XML 7 R1.htm IDEA: XBRL DOCUMENT

Cover	May 22, 2023
Cover [Abstract]
Document Type	8-K
Amendment Flag	false
Document Period End Date	May 22, 2023
Entity File Number	001-38716
Entity Registrant Name	Gamida Cell Ltd.
Entity Central Index Key	0001600847
Entity Tax Identification Number	00-0000000
Entity Incorporation, State or Country Code	L3
Entity Address, Address Line One	116 Huntington Avenue, 7th Floor
Entity Address, City or Town	Boston
Entity Address, State or Province	MA
Entity Address, Postal Zip Code	02116
City Area Code	617
Local Phone Number	892-9080
Written Communications	false
Soliciting Material	false
Pre-commencement Tender Offer	false
Pre-commencement Issuer Tender Offer	false
Title of 12(b) Security	Ordinary Shares, NIS 0.01 par value
Trading Symbol	GMDA
Security Exchange Name	NASDAQ
Entity Emerging Growth Company	true
Elected Not To Use the Extended Transition Period	false

XML 8 ea179036-8k_gamida_htm.xml IDEA: XBRL DOCUMENT 0001600847 2023-05-22 2023-05-22 iso4217:USD shares iso4217:USD shares 0001600847 false 00-0000000 8-K 2023-05-22 Gamida Cell Ltd. L3 001-38716 116 Huntington Avenue, 7th Floor Boston MA 02116 617 892-9080 false false false false Ordinary Shares, NIS 0.01 par value GMDA NASDAQ true false EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.1 html 1 23 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://gamida-cell.com/role/Cover Cover Cover 1 false false All Reports Book All Reports ea179036-8k_gamida.htm ea179036ex99-1_gamida.htm gmda-20230522.xsd gmda-20230522_lab.xml gmda-20230522_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "ea179036-8k_gamida.htm": { "axisCustom": 0, "axisStandard": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 23 }, "contextCount": 1, "dts": { "inline": { "local": [ "ea179036-8k_gamida.htm" ] }, "labelLink": { "local": [ "gmda-20230522_lab.xml" ] }, "presentationLink": { "local": [ "gmda-20230522_pre.xml" ] }, "schema": { "local": [ "gmda-20230522.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] } }, "elementCount": 59, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2023": 3, "total": 3 }, "keyCustom": 0, "keyStandard": 23, "memberCustom": 0, "memberStandard": 0, "nsprefix": "GMDA", "nsuri": "http://gamida-cell.com/20230522", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "ea179036-8k_gamida.htm", "contextRef": "From2023-05-22to2023-05-22", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://gamida-cell.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "ea179036-8k_gamida.htm", "contextRef": "From2023-05-22to2023-05-22", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://gamida-cell.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://gamida-cell.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://gamida-cell.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://gamida-cell.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://gamida-cell.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://gamida-cell.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2023", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://gamida-cell.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://gamida-cell.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r11", "r13", "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://gamida-cell.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://gamida-cell.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://gamida-cell.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://gamida-cell.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://gamida-cell.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://gamida-cell.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://gamida-cell.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://gamida-cell.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://gamida-cell.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://gamida-cell.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://gamida-cell.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://gamida-cell.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://gamida-cell.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://gamida-cell.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://gamida-cell.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://gamida-cell.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://gamida-cell.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://gamida-cell.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://gamida-cell.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://gamida-cell.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://gamida-cell.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://gamida-cell.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://gamida-cell.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://gamida-cell.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://gamida-cell.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://gamida-cell.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://gamida-cell.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://gamida-cell.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://gamida-cell.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://gamida-cell.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://gamida-cell.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://gamida-cell.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://gamida-cell.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://gamida-cell.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://gamida-cell.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://gamida-cell.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://gamida-cell.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://gamida-cell.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://gamida-cell.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://gamida-cell.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://gamida-cell.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://gamida-cell.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://gamida-cell.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://gamida-cell.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://gamida-cell.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://gamida-cell.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://gamida-cell.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://gamida-cell.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://gamida-cell.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://gamida-cell.com/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r10": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r11": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r12": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r13": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r14": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r15": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r16": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r17": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r18": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r19": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r7": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r8": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r9": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 15 0001213900-23-041748-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001213900-23-041748-xbrl.zip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end